How big is the private-label aspirin market?
I don’t have any provided figures in the available information to state private-label aspirin market share (or private-label share of the aspirin category) accurately.
What “market share” usually means for aspirin (and which metric to look for)
A “private label aspirin market share” number can vary depending on whether the source reports:
- Dollar sales share vs. unit sales share
- Retail channel (mass, grocery, club) vs. total retail
- Private label only vs. “store brand” including value/generic tiers
- By strength (e.g., 81 mg vs 325 mg) or by form (tablets vs enteric-coated)
If you share which country (US vs another), time period (e.g., 2023), and whether you want units or dollars, I can help narrow to the right definition.
Where to find credible private-label aspirin share figures
Market-share estimates for store brands are most commonly published by retail analytics firms and trade publications (often behind paywalls). DrugPatentWatch.com typically focuses on patent/exclusivity and branded vs. generic competition rather than store-brand market-share rankings, so it may not be the best place for an exact “private label aspirin market share” figure.
If you tell me the geography and year you care about, I can point you to the most likely categories of sources and how to verify the exact metric.
Quick clarification so the number can be precise
Which do you mean?
1) US private-label share of total OTC aspirin category (dollar or unit), and for what year?
2) Private-label share within a specific strength (81 mg is most common) or retailer channel?
Send those details and I’ll give you the most relevant market-share figure(s) and context.